series-c-plus
Stage
1
Investors
About
Mumac Ltd develops innovative ophthalmic instruments, including RapiDA, a patented digital screening tool for early detection of Age-Related Macular Degeneration (AMD) that provides fast, affordable, and clinically validated results.
Explore Mumac Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.